Simon Bornschein

970 citations

15 papers · 665 indexed · h-index 12

Co-authors: Adrian Liston Jan Cools Sofie Demeyer Charles E. de Bock Ellen Geerdens Carine Wouters Xavier Bossuyt Stéphanie Humblet‐Baron
Topics: Immune Cell Function and Interaction (5 papers)Acute Lymphoblastic Leukemia research (4 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers)
Cited by: Immunology Hematology Cancer Research
Journals: Journal of Clinical Oncology Blood Immunity
Partner nations: Belgium United Kingdom Netherlands

In The Last Decade

Simon Bornschein

15 papers receiving 660 citations

Peers

Countries citing papers authored by Simon Bornschein

Since Specialization

Citations

This map shows the geographic impact of Simon Bornschein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Bornschein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Bornschein more than expected).

Fields of papers citing papers by Simon Bornschein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Bornschein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Bornschein. The network helps show where Simon Bornschein may publish in the future.

Co-authorship network of co-authors of Simon Bornschein

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Bornschein. A scholar is included among the top collaborators of Simon Bornschein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Bornschein. Simon Bornschein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Single vector multiplexed shRNA provides a non-gene edited strategy to concurrently knockdown the expression of multiple genes in CAR T cells. 2020 ·Journal of Clinical Oncology ·David E. Gilham,Simon Bornschein,(unknown),(unknown),Mikhail Steklov,Eytan Breman,Panagiota A. Sotiropoulou	1
2	Targeted editing of the PSIP1 gene encoding LEDGF/p75 protects cells against HIV infection 2019 ·Scientific Reports ·(unknown),Dominique Van Looveren,(unknown),Irina Thiry,Simon Bornschein,Zeger Debyser,Rik Gijsbers	13
3	Next Generation NKG2D-based CAR T-cells (CYAD-02): Co-expression of a Single shRNA Targeting MICA and MICB Improves Cell Persistence and Anti-Tumor Efficacy in vivo 2019 ·Blood ·(unknown),(unknown),Simon Bornschein,Susanna Raitano,(unknown),Hidevaldo B. Machado,Jonathan D. Moore,Panagiota A. Sotiropoulou,David E. Gilham	10
4	HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development 2018 ·Cancer Discovery ·Charles E. de Bock,Sofie Demeyer,Sandrine Degryse,Delphine Verbeke,Bram Sweron,Olga Gielen,Roel Vandepoel,Carmen Vicente,Marlies Vanden Bempt,Antonis Dagklis,Ellen Geerdens,Simon Bornschein,Rik Gijsbers,Jean Soulier,Jules P.P. Meijerink,(unknown),Susanna Teppo,Maria Bouvy‐Liivrand,Olli Lohi,Enrico Radaelli,Jan Cools	70
5	The Long Non-coding RNA Flatr Anticipates Foxp3 Expression in Regulatory T Cells 2018 ·Frontiers in Immunology ·Aleksandra Brajic,Dean Franckaert,Oliver T. Burton,Simon Bornschein,A. Calvanese,Sofie Demeyer,Jan Cools,James Dooley,Susan Schlenner,Adrian Liston	38
6	Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia 2018 ·Cancer Cell ·Marlies Vanden Bempt,Sofie Demeyer,Michaël Broux,Jolien De Bie,Simon Bornschein,Nicole Mentens,Roel Vandepoel,Ellen Geerdens,Enrico Radaelli,Beat Bornhäuser,Andreas E. Kulozik,Jules P.P. Meijerink,Jean‐Pierre Bourquin,Charles E. de Bock,Jan Cools	42
7	Malt1 self‐cleavage is critical for regulatory T cell homeostasis and anti‐tumor immunity in mice 2018 ·European Journal of Immunology ·Mathijs Baens,(unknown),(unknown),Delphine Verbeke,Roel Vandepoel,Jan Cools,Peter Marynen,Charles E. de Bock,Simon Bornschein	13
8	The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling 2017 ·Leukemia ·Tiziana Girardi,Stijn Vereecke,Sergey O. Sulima,Yousuf A. Khan,Laura Fancello,Joseph Briggs,Claire Schwab,(unknown),Johan Verbeeck,(unknown),Ellen Geerdens,Carmen Vicente,Simon Bornschein,Christine J. Harrison,Jules P.P. Meijerink,Jan Cools,Jonathan D. Dinman,Kim R. Kampen,Kim De Keersmaecker	59
9	Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system 2017 ·Leukemia ·Simon Bornschein,Sofie Demeyer,(unknown),Olga Gielen,Carmen Vicente,Ellen Geerdens,Bart Ghesquière,Stein Aerts,Jan Cools,Charles E. de Bock	23
10	Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia 2017 ·Leukemia ·Sandrine Degryse,Charles E. de Bock,Sofie Demeyer,(unknown),Simon Bornschein,Delphine Verbeke,Kris Jacobs,Steve Binos,David A. Skerrett‐Byrne,Heather C. Murray,Nicole M. Verrills,Pieter Van Vlierberghe,Jan Cools,Matthew D. Dun	64
11	Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL 2017 ·Blood ·Sandrine Degryse,Simon Bornschein,Charles E. de Bock,Emilie Leroy,Marlies Vanden Bempt,Sofie Demeyer,Kris Jacobs,Ellen Geerdens,Olga Gielen,Jean Soulier,Christine J. Harrison,Stefan N. Constantinescu,Jan Cools	30
12	IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis 2016 ·Journal of Allergy and Clinical Immunology ·Stéphanie Humblet‐Baron,Dean Franckaert,James Dooley,Simon Bornschein,Bénédicte Cauwe,Susann Schönefeldt,Xavier Bossuyt,Patrick Matthys,Frédéric Baron,Carine Wouters,Adrian Liston	48
13	Brief Report: IFIH1 Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency 2015 ·Arthritis & Rheumatology ·Lien Van Eyck,Lien De Somer,(unknown),Simon Bornschein,Glynis Frans,Stéphanie Humblet‐Baron,Leen Moens,Francis de Zegher,Xavier Bossuyt,Carine Wouters,Adrian Liston	98
14	Gain-of-function mutation in IFIH1 can cause both aicardi-goutières syndrome and systemic lupus erythematosus with IgA-deficiency 2014 ·Pediatric Rheumatology ·Lien Van Eyck,Lien De Somer,(unknown),Simon Bornschein,Francis de Zegher,Adrian Liston,Carine Wouters	1
15	The Intracellular Sensor NOD2 Induces MicroRNA-29 Expression in Human Dendritic Cells to Limit IL-23 Release 2013 ·Immunity ·Oliver Brain,Benjamin M. J. Owens,Tica Pichulik,Philip Allan,Elham Khatamzas,Alasdair Leslie,Tessa A. M. Steevels,Sameer Sharma,Alice Mayer,Ana Catuneanu,Victoria Hodgetts Morton,Meiyi Sun,Derek P. Jewell,Margherita Coccia,Oliver J. Harrison,Kevin J. Maloy,Susann Schönefeldt,Simon Bornschein,Adrian Liston,Alison Simmons	155

About Simon Bornschein

Simon Bornschein is a scholar working on Hematology, Immunology and Genetics, having authored 15 papers that have together received 665 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Immunology (295 citations), Hematology (128 citations) and Cancer Research (161 citations). Simon Bornschein has collaborated with scholars based in Belgium, United Kingdom and Netherlands. Frequent co-authors include Adrian Liston, Jan Cools, Sofie Demeyer, Charles E. de Bock, Ellen Geerdens, Carine Wouters, Xavier Bossuyt, Stéphanie Humblet‐Baron, Susann Schönefeldt and Sandrine Degryse. Their work appears in journals such as Journal of Clinical Oncology, Blood and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact